References
- Qureshi F, Hahn J. Towards the development of a diagnostic test for autism spectrum disorder: big data meets metabolomics. Can J Chem Eng. 2023, Jan;101(1):9–17.
- Sauer AK, et al. Autism spectrum disorders: etiology and pathology. Brisbane (AU): Exon Publications; 2021. p. 1–15.
- Loussouarn A, Dozières-Puyravel B, Auvin S. Autistic spectrum disorder and epilepsy: diagnostic challenges. Expert Rev Neurother. 2019;19(6):579–85.
- Hong E, Matson JL. Factors associated with restricted, repetitive behaviors and interests and diagnostic severity level ratings in young children with autism spectrum disorder. J Autism Dev Disord. 2021;51(12):4644–54.
- Bonaz B, et al. Diseases, disorders, and comorbidities of interoception. Trends Neurosci. 2021;44(1):39–51.
- Sztainberg Y, Zoghbi HY. Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci. 2016;19(11):1408–17.
- Fernandez BA, Scherer SW. Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach. Dialog Clin Neurosci. 2017, Dec;19(4):353–371.
- Fetit R, et al. The neuropathology of autism: a systematic review of post-mortem studies of autism and related disorders. Neurosci Biobehav Rev. 2021;129:35–62.
- Sathyanesan A, et al. Emerging connections between cerebellar development, behaviour and complex brain disorders. Nat Rev Neurosci. 2019;20(5):298–313.
- Abdel-Moneim A-ME, et al. Antioxidant and antimicrobial activities of Spirulina platensis extracts and biogenic selenium nanoparticles against selected pathogenic bacteria and fungi. Saudi J Biol Sci. 2022;29(2):1197–209.
- Eleiwa NZH, et al. Antioxidant activity of Spirulina platensis alleviates doxorubicin-induced oxidative stress and reprotoxicity in male rats. Orient Pharm Exp Med. 2018;18(2):87–95.
- Ali EA, Barakat BM, Hassan R. Antioxidant and angiostatic effect of Spirulina platensis suspension in complete Freund’s adjuvant-induced arthritis in rats. PLoS One. 2015;10(4):e0121523.
- Wu Q, et al. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch Toxicol. 2016;90(8):1817–40.
- Fadl SE, et al. Ameliorative effect of Spirulina and Saccharomyces cerevisiae against fipronil toxicity in Oreochromis niloticus. Ecotoxicol Environ Saf. 2022;242:113899.
- Lima FAV, et al. Neuroprotective activities of Spirulina platensis in the 6-OHDA model of Parkinson’s disease are related to its anti-inflammatory effects. Neurochem Res. 2017;42(12):3390–400.
- Trotta T, et al. Beneficial effects of spirulina consumption on brain health. Nutrients. 2022;14(3):676.
- Yousef MI, et al. Neuroprotective potential of Spirulina platensis against aluminium chloride-induced neural degeneration. Curr Top Nutraceut Res. 2020;18:4.
- Sorrenti V, et al. Spirulina microalgae and brain health: a scoping review of experimental and clinical evidence. Mar Drugs. 2021;19(6):293.
- Eshraghi AA, et al. Genetic ablation of metabotropic glutamate receptor 5 in rats results in an autism-like behavioral phenotype. PLoS One. 2022;17(11):e0275937.
- Puig-Lagunes AA, et al. Pentylenetetrazole-induced seizures in developing rats prenatally exposed to valproic acid. PeerJ. 2016;4:e2709.
- Alqahtani MJ, et al. Encephalartos villosus Lem. displays a strong in vivo and in vitro antifungal potential against Candida glabrata clinical isolates. J Fungi. 2022;8(5):521.
- Negm WA, et al. Promising antifungal activity of Encephalartos laurentianus de wild against Candida albicans clinical isolates: in vitro and in vivo effects on renal cortex of adult albino rats. J Fungi. 2022;8(5):426.
- Attallah NGM, et al. Elucidation of phytochemical content of cupressus macrocarpa leaves: in vitro and in vivo antibacterial effect against methicillin-resistant Staphylococcus aureus clinical isolates. Antibiotics. 2021;10(8):890.
- Tsugawa H, et al. MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12(6):523–26.
- Dendrinos G, Hemelt M, Keller A. Prenatal VPA exposure and changes in sensory processing by the superior colliculus. Front Integr Neurosci. 2011;5:68.
- Sinha S, et al. Amelioration of neurobehavioral and cognitive abilities of F1 progeny following dietary supplementation with Spirulina to protein malnourished mothers. Brain Behav Immunity. 2020;85:69–87.
- Allen-Worthington KH, et al. Intraperitoneal injection of ethanol for the euthanasia of laboratory mice (Mus musculus) and rats (Rattus norvegicus). J Am Assoc Lab Anim Sci. 2015;54(6):769–78.
- Jiji KN, Muralidharan P. Evaluation of the protective effect of Clitoria ternatea L. against propionic acid induced autistic spectrum disorders in rat model. Bull Natl Res Centre. 2022;46(1):1–11.
- Rahi S, et al. Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum Exp Toxicol. 2021;40(11):1880–98.
- Ahmadi F, et al. Effect of resistance training with Spirulina platensis on PI3 K/Akt/mTOR/p70S6k signaling pathway in cardiac muscle. Sci Sports. 2020;35(2):91–98.
- Bancroft JD. The hematoxylins and eosin/connective and other mesenchymal tissues with their stains. In: KS Suvarna, C Layton, JD Bancroft, editors. Bancroft’s theory and practice of histological techniques e-book. London: Elsevier Health Sciences; 2019. p. 121–132.
- Mohamed BM, et al. Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-α and indoleamine 2, 3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats. Neuropsychiatr Dis Treat. 2013;9:697.
- Kazlauskas N, et al. Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: relevance for susceptibility and resilience in autism. Psychoneuroendocrinology. 2019;110:104441.
- Milner V, et al. A qualitative exploration of the female experience of autism spectrum disorder (ASD). J Autism Dev Disord. 2019;49(6):2389–402.
- Pei L, Wallace DC. Mitochondrial etiology of neuropsychiatric disorders. Biol Psychiatry. 2018;83(9):722–30.
- Lord C, et al. Autism spectrum disorder. Nat Rev Disease Prim. 2020;6(1):1–23.
- Marles RJ, et al. United States pharmacopeia safety evaluation of Spirulina. Crit Rev Food Sci Nutr. 2011;51(7):593–604.
- Jensen GS, et al. Clinical safety of a high dose of phycocyanin-enriched aqueous extract from Arthrospira (Spirulina) platensis: results from a randomized, double-blind, placebo-controlled study with a focus on anticoagulant activity and platelet activation. Random Contr Trial. 2016;19(7):645–53.
- Negm WA, et al. Hepatoprotective, cytotoxic, antimicrobial and antioxidant activities of Dioon spinulosum leaves Dyer Ex Eichler and its isolated secondary metabolites. Nat Prod Res. 2021;35(23):5166–76.
- Negm WA, et al. A new cytotoxic and antioxidant amentoflavone monoglucoside from Cycas revoluta Thunb growing in Egypt. J Pharmaceut Sci Res. 2016;8(5):343.
- Ibrahim AE, Abdel-Daim MM. Modulating effects of Spirulina platensis against tilmicosin-induced cardiotoxicity in mice. Cell J. 2015;17(1):137.
- Singh U, et al. Identification of antifungal and antibacterial biomolecules from a cyanobacterium, Arthrospira platensis. Algal Res. 2021;54:102215.
- Syarina PNA, et al. Wound healing potential of Spirulina platensis extracts on human dermal fibroblast cells. Excli J. 2015;14:385.
- Sharma A, Bhalla S, Mehan S. PI3 K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats. Metab Brain Dis. 2022;37(6):1–21.
- Zhou T, et al. Spirulina platensis alleviates high fat diet-induced cognitive impairment in mice via the gut-brain axis. J Funct Foods. 2021;86:104706.
- Shen M, et al. Metformin facilitates osteoblastic differentiation and M2 macrophage polarization by PI3 K/AKT/mTOR pathway in human umbilical cord mesenchymal stem cells. Stem Cells Int. 2022;18:9498876.
- Ganesan H, et al. mTOR signalling pathway-a root cause for idiopathic autism? BMB Rep. 2019;52(7):424.
- Arab S, et al. Chemopreventive effect of spirulina microalgae on an animal model of glioblastoma via down-regulation of PI3 K/AKT/mTOR and up-regulation of miR-34a/miR-125B expression. Phytother Res. 2021;35(11):6452–61.
- Liu X, et al. Oxidative stress in autism spectrum disorder (ASD) – current progress of mechanisms and biomarkers. Front Psychiatry. 2022;13:813304.
- Taleb A, et al. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment. Biomed Pharmacother. 2021;137:111322.
- Mao S, et al. Role of PI3 K/AKT/mTOR pathway associated oxidative stress and cardiac dysfunction in takotsubo syndrome. Curr Neurovasc Res. 2020;17(1):35–43.
- Cristiano C, et al. Behavioral, anti-inflammatory, and neuroprotective effects of a novel FPR2 agonist in two mouse models of autism. Pharmaceuticals. 2022;15(2):161.
- Nadeem A, et al. Differential regulation of Nrf2 is linked to elevated inflammation and nitrative stress in monocytes of children with autism. Psychoneuroendocrinology. 2020;113:104554.
- Wong RS. Neuroinflammation in autism spectrum disorders: potential target for mesenchymal stem cell-based therapy. Egypt J Neurol Psychiatry Neurosurg. 2022;58(1):1–13.
- Wang B, et al. mTOR signaling pathway regulates the release of proinflammatory molecule CCL5 implicated in the pathogenesis of autism spectrum disorder. Front Immunol. 2022;13:818518.
- Brito AdF, et al. Spirulina platensis prevents oxidative stress and inflammation promoted by strength training in rats: dose-response relation study. Sci Rep. 2020;10(1):1–8.
- Dong D, et al. Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder. Autism Res. 2018;11(7):1076–90.
- Tayubi IA, Shome S, Hashmi S. Drug formulation studies on regulation of BCL-2 family for treatment of autism. BMC Genomics. 2014;15(2):1–2.
- Kim J-E, et al. Treadmill exercise ameliorates motor disturbance through inhibition of apoptosis in the cerebellum of valproic acid-induced autistic rat pups. Mol Med Rep. 2013;8(2):327–34.
- Pangrazzi L, Balasco L, Bozzi Y. Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci. 2020;21(9):3293.
- Gondo HK. The effect of spirulina on apoptosis through the caspase-3 pathway in a Preeclamptic Wistar rat model. J Nat Sci Biol Med. 2021;12(3):280–84.
- Pagani M, et al. mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity. Nat Commun. 2021;12(1):1–15.
- Liang Y, et al. Spirulina supplementation improves lipid metabolism and autophagic activities in the liver and muscle of Hu lambs fed a high-energy diet. Arch Anim Nutr. 2020;74(6):476–95.
- Vilahur G, et al. Supplementation with spirulina reduces infarct size and ameliorates cardiac function in a pig model of STEMI. Front Pharmacol. 2022;13:891801.
- Hou Q, et al. A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-treated rat model of autism. Front Behav Neurosci. 2018;12:182.
- Reinhardt VP, et al. Understanding hippocampal development in young children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2020;59(9):1069–79.
- Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in Autism Spectrum Disorder. Brain Behav Immun. 2019;79:75–90.
- Banerjee A, et al. Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. Int J Neuropsuchopharmacolog. 2013;16(6):1309–18.
- Han S, et al. Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission. Nature. 2012;489(7416):385–90.
- Lee E, Lee J, Kim E. Excitation/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry. 2017;81(10):838–47.
- Xu N, Li X, Zhong Y. Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediat Inflamm. 2015;2015:531518.